FDA Approved: DICLOFENAC SODIUM 1.5% — Supplemental Application (SOLA Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for diclofenac sodium 1.5% topical from SOLA Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Diclofenac Sodium 1.5% topical (diclofenac sodium topical)

Snippet

SUPPL AP for DICLOFENAC SODIUM 1.5% (DICLOFENAC SODIUM TOPICAL)